Keyphrases
Adverse Effects
29%
AIDS/HIV
29%
Air Pollution
29%
Air Pollution Exposure
29%
Allergy Immunology
29%
Antibody Response
58%
Antibody Titre
29%
Atopy
29%
Booster Dose
29%
Breakthrough Infection
29%
Children's Activities
29%
COVID-19
32%
COVID-19 Vaccine Booster
29%
East Java Indonesia
33%
Elderly Adults
29%
Food Allergy
32%
Graves' Disease
58%
Healthcare Workers
87%
Hospital Workers
29%
Hypertension
47%
IgG Levels
41%
Immunoglobulin E
29%
Inactivated SARS-CoV-2
29%
Indonesia
41%
Internist
29%
Lung Physiology
29%
Meningococcal Vaccination
29%
MRNA Vaccine
29%
Nutritional Status
29%
Older Adults
29%
Ophtalmopathy
29%
Pneumonia
29%
Pneumonia Vaccination
29%
Polysaccharide
29%
PPSV23
29%
Pulmonary Tuberculosis
29%
Respiratory Organs
29%
Response Effects
29%
Retrospective Cohort Study
29%
Rifampicin
29%
Running Head
29%
SARS-CoV-2 Infection
34%
Serum IgE
41%
Serum Levels
33%
Stevens-Johnson Syndrome
29%
Thyrotropin Receptor Antibody (TRAb)
58%
Traffic Police
29%
Vaccination
100%
Vaccination Program
29%
Whole-cell Vaccine
40%
Pharmacology, Toxicology and Pharmaceutical Science
Acquired Immune Deficiency Syndrome
29%
Adverse Event
29%
Atopy
29%
Cohort Study
29%
Coronavirinae
39%
COVID-19 Vaccine
29%
Cross-Sectional Study
7%
Diabetes Mellitus
19%
Diseases
63%
Endocrine Ophthalmopathy
9%
Enzyme-Linked Immunosorbent Assay
24%
Ethambutol
14%
Eye Disease
24%
Graves Disease
58%
Hypertension
7%
Immunoglobulin E
29%
Inactivated Virus Vaccine
7%
Infection
82%
Lung Tuberculosis
29%
Medical History
14%
Messenger RNA
29%
mRNA Vaccine
29%
Pneumococcus Polysaccharide
29%
Polysaccharide
29%
Receptor
9%
Receptor Antibody
58%
Respiratory Tract Infection
14%
Retrospective Study
14%
Rifampicin
29%
SARS Coronavirus
77%
Stevens Johnson Syndrome
29%
Thyrotropin Receptor
58%
Toxic Epidermal Necrolysis
9%
Vaccination
29%
Virus Vaccine
47%
Medicine and Dentistry
Acquired Immune Deficiency Syndrome
9%
Adverse Effect
29%
Adverse Event
12%
Antibody Response
58%
Blood Pressure
7%
Body Mass Index
7%
Booster Dose
29%
Community Health
14%
COVID-19
43%
COVID-19 Vaccine
29%
Demography
7%
Deterioration
14%
Diabetes Mellitus
8%
Diphtheria Toxoid CRM197
29%
Diseases
9%
Enzyme Linked Immunosorbent Assay
29%
Ethambutol
14%
Health Care
41%
Hypertension
7%
Immune Response
14%
Immune System
14%
Immunosenescence
29%
Inactivated Virus Vaccine
7%
Infection
91%
Lung Tuberculosis
29%
Medical Examination
7%
Medical History
14%
Meningococcal Disease
14%
Messenger RNA
12%
mRNA Vaccine
29%
Patient with Acquired Immune Deficiency Syndrome
29%
Pneumococcus Polysaccharide
29%
Polysaccharide
29%
Pressure Control
7%
Quality of Life
14%
Rank Sum Test
14%
Respiratory Tract Infection
14%
Retrospective Cohort Study
29%
Retrospective Study
14%
Rifampicin
29%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Stevens-Johnson Syndrome
29%
Student T Test
14%
Toxic Epidermal Necrolysis
9%
Virus Inactivation
7%
Virus Vaccine
31%